APIM
TECH icon

Agate Pass Investment Management’s Bio-Techne TECH Stock Holding History

Agate Pass Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,776
Closed -$230K – 98
2021
Q4 		$230K Buy
+1,776
New +$218K 0.14% 94

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Agate Pass Investment Management's TECH Position: Q1 2022 in Review

Agate Pass Investment Management sold out of Bio-Techne (TECH) in Q1 2022, closing a stake of 1,776 shares — an estimated $230K sold.

Agate Pass Investment Management first reported a position in TECH in Q4 2021 and held it in 1 quarter. The position peaked at $230K in Q4 2021. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

  • Agate Pass Investment Management reported no remaining Bio-Techne position as of Q1 2022 after selling out during the quarter.
  • Agate Pass Investment Management sold 1,776 Bio-Techne shares in Q1 2022, an estimated $230K.
  • Agate Pass Investment Management first reported a position in Bio-Techne in Q4 2021 and held it in 1 quarter.
  • Agate Pass Investment Management's Bio-Techne position peaked at $230K in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Agate Pass Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.